Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis (NCT05322070)

🧪 Interventions in This Study

• Fluocinolone Acetonide Intravitreal Implant 0.18 mg (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (23 Sites)

• Retina Consultants of Orange County — Fullerton, California
• Macula and Retina Institute — Glendale, California
• California Eye Specialists Medical Group — Pasadena, California
• Retinal Consultants Medical Group — Sacramento, California
• Retina Associates of Colorado — Lakewood, Colorado
• Advanced Research — Coral Springs, Florida
• Retina Specialists of Tampa — Wesley Chapel, Florida
• Marietta Eye Clinic — Marietta, Georgia
• Retinal Vitreal Consultants Ltd. — Chicago, Illinois
• Illinois Retina Associates, S.C. — Oak Park, Illinois
• Cumberland Valley Retina Consultants — Hagerstown, Maryland
• Opthalmic Consultants of Boston — Boston, Massachusetts
• Massachusets Eye Research and Surgery Institution — Waltham, Massachusetts
• Foundation for Vision Research — Grand Rapids, Michigan
• Midwest Vision Research Foundation at Pepose Vision Institute — Chesterfield, Missouri
• Retina Consultants — Fargo, North Dakota
• Retina Vitreous Associates — Toledo, Ohio
• Erie Retina Research, LLC — Erie, Pennsylvania
• Tennessee Retina — Nashville, Tennessee
• Retina Consultants of Texas — Bellaire, Texas
• Retina Consultants of Texas — Katy, Texas
• Valley Retina Institute, PA — McAllen, Texas
• Medical Center Opthalmology Associates — San Antonio, Texas

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Uveitis, Posterior

• A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis — Phoenix, Arizona

Explore by condition: All Uveitis, Posterior clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.